These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31913906)

  • 1. Comment on "Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Scleral Technique: A Single-Center, Sequential, and Controlled Study".
    Yin M; Li H; Zhang Y; Dai H; Luo F; Pan Z
    Cornea; 2020 Apr; 39(4):e14. PubMed ID: 31913906
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on: "Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study".
    Gupta B; Sahay P; Kumawat D
    Cornea; 2020 Apr; 39(4):e13-e14. PubMed ID: 31789921
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study.
    Yin M; Li H; Zhang Y; Dai H; Luo F; Pan Z
    Cornea; 2019 Oct; 38(10):1239-1244. PubMed ID: 31299663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison among adjuvant treatments for primary pterygium: a network meta-analysis.
    Fonseca EC; Rocha EM; Arruda GV
    Br J Ophthalmol; 2018 Jun; 102(6):748-756. PubMed ID: 29146761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute scleral thinning after pterygium excision with intraoperative mitomycin C: a case report of scleral dellen after bare sclera technique and review of the literature.
    Tsai YY; Lin JM; Shy JD
    Cornea; 2002 Mar; 21(2):227-9. PubMed ID: 11862102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pterygium surgery with mitomycin C: how much sclera should be left bare?
    Avisar R; Weinberger D
    Cornea; 2003 Nov; 22(8):721-5. PubMed ID: 14576522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of single-drop mitomycin C regime with other mitomycin C regimes in pterygium surgery.
    Gupta VP; Saxena T
    Indian J Ophthalmol; 2003 Mar; 51(1):59-65. PubMed ID: 12701864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis on the recurrence rates after bare sclera resection with and without mitomycin C use and conjunctival autograft placement in surgery for primary pterygium.
    Sánchez-Thorin JC; Rocha G; Yelin JB
    Br J Ophthalmol; 1998 Jun; 82(6):661-5. PubMed ID: 9797669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single intraoperative application versus postoperative mitomycin C eye drops in pterygium surgery.
    Cardillo JA; Alves MR; Ambrosio LE; Poterio MB; Jose NK
    Ophthalmology; 1995 Dec; 102(12):1949-52. PubMed ID: 9098301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mitomycin C in pterygium surgery.
    Mahar PS; Nwokora GE
    Br J Ophthalmol; 1993 Jul; 77(7):433-5. PubMed ID: 8343473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology.
    Kaufman SC; Jacobs DS; Lee WB; Deng SX; Rosenblatt MI; Shtein RM
    Ophthalmology; 2013 Jan; 120(1):201-8. PubMed ID: 23062647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scleral melting 16 years after pterygium excision with topical Mitomycin C adjuvant therapy.
    Wan Norliza WM; Raihan IS; Azwa JA; Ibrahim M
    Cont Lens Anterior Eye; 2006 Sep; 29(4):165-7. PubMed ID: 16938484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospective study of surgical therapy of pterygium: bare sclera technique vs. free conjunctiva-limbus transplant].
    Hille K; Höh H; Gross A; Ruprecht KW
    Ophthalmologe; 1996 Jun; 93(3):224-6. PubMed ID: 8753981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of the technique of complete tenon's membrane excision and mitomycin C in pterygium surgery.
    Levy RL; Naidu S; Jacobson L
    Eye Contact Lens; 2005 May; 31(3):105-8. PubMed ID: 15894875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis.
    Bayer A; Mutiu FM; Sobaci G
    Ophthalmic Surg Lasers; 2001; 32(6):490-3. PubMed ID: 11725777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pterygium--menace, lying in wait].
    Robaszkiewicz J; Mrzygłód S
    Klin Oczna; 2003; 105(1-2):95-9. PubMed ID: 12866185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis.
    Bayer A; Mutlu FM; Sobaci G
    Ophthalmic Surg Lasers; 2002; 33(1):58-61. PubMed ID: 11820665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing mitomycin C and conjunctival autograft after excision of primary pterygium.
    Chen PP; Ariyasu RG; Kaza V; LaBree LD; McDonnell PJ
    Am J Ophthalmol; 1995 Aug; 120(2):151-60. PubMed ID: 7639298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results after bare sclera pterygium resection with excimer smoothing and local application of mitomycin C.
    Walkow T; Daniel J; Meyer CH; Rodrigues EB; Mennel S
    Cornea; 2005 May; 24(4):378-81. PubMed ID: 15829791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence rate with use of intraoperative Mitomycin C versus Conjunctival Autograft following pterygium excision.
    Paracha Q; Ayoob M; Dawood Z; Mirza SA
    Pak J Med Sci; 2014; 30(6):1243-6. PubMed ID: 25674116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.